Genetics of endometriosis

Women's Health

Volumn 11, Issue 5, 2015, Pages 577-586

  Rahmioglu, Nilufer ^a   Montgomery, Grant W ^b   Zondervan, Krina T ^a,c  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

association studies; candidate gene studies; common genetic variants; functional studies; genome wide association studies; linkage studies; rare genetic variants; rhesus macaque; sub phenotype; twin studies

Indexed keywords

MICRORNA; MICRORNA 148A; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

CDKN2B AS1 GENE; CELL CYCLE PROGRESSION; CHROMOSOME 10Q; CYSTIC FIBROSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOMETRIOSIS; ESTROGEN METABOLISM; ETAA1 GENE; FN1 GENE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GREB1 GENE; HEREDITY; HOXA10 GENE; HUMAN; ID4 GENE; MORPHOLOGY; NFE2L3 GENE; NONHUMAN; OVIDUCT; PLESIOMORPHY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VEZT GENE; WNT4 GENE; ENDOMETRIUM; FEMALE; FEMALE INFERTILITY; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY;

ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFERTILITY, FEMALE; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84946150078     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.15.41     Document Type: Review

References (61)

1. Craig J. Complex diseases: research and applications. Nat. Educ. 1(1), 184 (2008).
2. Zondervan KT, Cardon LR, Kennedy SH. The genetic basis of endometriosis. Curr. Opin. Obstet. Gynecol. 13, 309-314 (2001).
3. Stefansson H, Geirsson RT, Steinthorsdottir V et al. Genetic factors contribute to the risk of developing endometriosis. Hum. Reprod. 17, 555-559 (2002).
4. Kennedy S, Mardon H, Barlow D. Familial endometriosis. J. Assist. Reprod. Genet. 12(1), 32-34 (1995).
5. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet. Gynecol. Clin. North Am. 24(2), 235-58 (1997).
6. Hadfield RM, Mardon HJ, Barlow DH et al. Endometriosis in monozygotic twins. Fertil. Steril. 68, 941-942 (1997).
7. Treloar SA, O'Connor DT, O'Connor VM et al. Genetic influences on endometriosis in an Australian twin sample. Fertil. Steril. 71, 701-710 (1999).
8. Zondervan KT, Weeks DE, Colman R et al. Familial aggregation of endometriosis in a large pedigree of rhesus macaques. Hum. Reprod. 19, 448-455 (2004).
9. Montgomery GW, Nyholt DR, Zhao ZZ et al. The search for genes contributing to endometriosis risk. Hum. Reprod. Update 14(5), 447-457 (2008).
10. Rahmioglu N, Missmer SA, Montgomery GW, Zondervan KT. Insights into assessing the genetics of endometriosis. Curr. Obstet. Gynecol. Rep. 1, 124-137 (2012).
11. Zondervan KT, Cardon LR. Designing candidate gene and genome-wide case-control association studies. Nat. Protoc. 2(10), 2492-2501 (2007).
12. Gloria-Bottini F, Ammendola M, Saccucci P, Pietropolli A, Magrini A, Bottini E. The association of PTPN22 polymorphism with endometriosis: effect of genetic and clinical factors. Eur. J. Obstet. Gynecol. Reprod. Biol. 169(1), 60-63 (2013).
13. Sahmani M, Ghaleh TD, Darabi M, Darabi M, Rashvand Z, Najafipour R. I405V polymorphism of CETP gene and lipid profile in women with endometriosis. Gynecol. Endocrinol. 29(7), 712-715 (2013).
14. Szczepaska M, Wirstlein P, Skrzypczak J, Jagodziski PP. Polymorphic variants of CYP17 and CYP19A and risk of infertility in endometriosis. Acta Obstet. Gynecol. Scand. 92(10), 1188-1193 (2013)
15. Bilibio JP, Matte U, de Conto E, Genro VK, Souza CA, Cunha-Filho JS. Dopamine receptor D2 genotype (3438) is associated with moderate/severe endometriosis in infertile women in Brazil. Fertil. Steril. 99(5), 1340-1345 (2013).
16. Wu ZY, Wang WW, Wang T et al. Association of FOXP3 gene polymorphism in Chinese women with endometriosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 30(1), 106-110 (2013).
17. Frare AB, Barbosa AM, Costa IR et al. GSTM1 and GSTT1 polymorphisms in endometriosis in women from Goiás, Brazil. Genet. Mol. Res. 12(3), 2764-2770 (2013).
18. Fan W, Li S, Chen Q, Huang Z, Ma Q, Xiao Z. Association between interleukin-10 promoter polymorphisms and endometriosis: a meta-analysis. Gene 515(1), 49-55 (2013)
19. Saliminejad K, Memariani T, Ardekani AM et al. Association study of the TNF-1031T/C and VEGF + 450G/C polymorphisms with susceptibility to endometriosis. Gynecol. Endocrinol. 29(11), 974-977 (2013).
20. Li YZ, Wang LJ, Li X et al. Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies. Genet. Mol. Res. 12(2), 1035-1044 (2013).
21. Vanaja MC, Rozati R, Nassaruddin K, Vishnupriya S. Association of VEGF +405G>C polymorphism with endometriosis. Front. Biosci. (Elite Ed.) 5, 748-754 (2013).
22. Kang S, Shi YY, Li Y et al. Association between genetic variants of the VEGFR-2 gene and the risk of developing endometriosis in northern Chinese women. Gynecol. Obstet. Invest. 76(1), 32-37 (2013).
23. Lin J, Zong L, Kennedy SH, Zondervan KT. Coding regions of INHBA, SFRP4 and HOXA10 are not implicated in familial endometriosis linked to chromosome 7p13-15. Mol. Hum. Reprod. 17, 605-611 (2011).
24. Treloar SA, Zhao ZZ, Le L et al. Variants in EMX2 and PTEN do not contribute to risk of endometriosis. Mol. Hum. Reprod. 13, 587-594 (2007).
25. Zhao ZZ, Nyholt DR, Le L, Treloar SA, Montgomery GW. Common variation in the CYP17A1 and IFIT1 genes on chromosome 10 does not contribute to the risk of endometriosis. Open Reprod. Sci. J. 1, 35-40 (2008).
26. Lander ES, Daly MJ. Multipoint linkage analysis of the cystic fibrosis region. Prog. Clin. Biol. Res. 329, 47-52 (1989).
27. Volkers WS, Went LN, Vegter-Van Der Vlis M, Harper PS, Caro A. Genetic linkage studies in Huntington's chorea. Ann. Hum. Genet. 44, 75-79 (1980).
28. Painter JN, Nyholt DR, Morris A et al. High-density finemapping of a chromosome 10q26 linkage peak suggests association between endometriosis and variants close to CYP2C19. Fertil. Steril. 95, 2236-2240 (2011).
29. Cribb AE, Knight MJ, Dryer D et al. Role of polymorphic human CYP450 enzymes in estrone oxidation. Cancer Epidemiol. Biomarkers Prev. 15, 551-558 (2006).
30. Lin J, Zong L, Kennedy SH et al. Coding regions of INHBA, SFRP4 and HOXA10 are not implicated in familial endometriosis linked to chromosome 7p13-15. Mol. Hum. Reprod. 17, 605-611 (2011).
31. The International HapMap C. A haplotype map of the human genome. Nature 437, 1299-1320 (2005)
32. Uno S, Zembutsu H, Hirasawa A et al. A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat. Genet. 42, 707-710 (2010).
33. Treloar SA, Wicks J, Nyholt DR et al. Genome-wide linkage study in 1,176 affected sister pair families identifies significant susceptibility locus for endometriosis on chromosome 20q26. Am. J. Hum. Genet. 77, 365-376 (2005).
34. Zondervan KT, Treloar SA, Lin J et al. Significant evidence of one or more susceptibility loci for endometriosis with near-Mendelian inheritance on chromosome 7p13-15. Hum. Reprod. 22, 717-728 (2007).
35. National Human Genome Research Institute. www.genome.gov/GWAStudies
36. Adachi S, Tajima A, Quan J et al. Meta-analysis of genome-wide association scans for genetic susceptibility to endometriosis in Japanese population. J. Hum. Genet. 55, 816-821 (2010).
37. Painter JN, Anderson CA, Nyholt DR et al. Genome-wide association study identifies a locus at 7p15.2 associated with the development of endometriosis. Nat. Genet. 43, 51-54 (2011).
38. Nyholt DR, Low SK, Anderson CA et al. Genome-wide association meta-analysis identified new endometriosis risk loci. Nat. Genet. 44(12), 1355-1359 (2012).
39. Albertsen HM, Chettier R, Farrington P, Ward K. Genomewide association study link novel loci to endometriosis. PLoS ONE 8, e58257 (2013).
40. Rahmioglu N, Nyholt DR, Morris AP, Missmer SA, Montgomery GW, Zondervan KT. Genetic variants underlying risk of endometriosis: insights from meta-analysis of eight genome-wide association and replication datasets. Hum. Reprod. Update 20(5), 702-716 (2014).
41. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP. Female development in mammals is regulated by Wnt-4 signalling. Nature 397, 405-409 (1999).
42. Gaetje R, Holtrich U, Engels K et al. Endometriosis may be generated by mimicking the ontogenetic development of the female genital tract. Fertil. Steril. 87, 651-656 (2007).
43. Pellegrini C, Gori I, Achtari C et al. The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis. Fertil. Steril. 98, 1200-1208 (2012).
44. Borowski A, Dirksen U, Lixin L, Shi RL, Göbel U, Schneider EM. Structure and function of ETAA16: a novel cell surface antigen in Ewing's tumours. Cancer Immunol. Immunother. 55, 363-374 (2006).
45. Pankov R, Yamada KM. Fibronectin at a glance. J. Cell Sci. 115, 3861-3863 (2002).
46. Lou X, Han X, Jin C et al. SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention. OMICS 17(10), 510-518 (2013).
47. Verschuur-Maes AH, de Bruin PC, van Diest PJ. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer. Breast Cancer Res. Treat. 136, 705-715 (2012).
48. Ren Y, Cheung HW, von Maltzhan G et al. Targeted tumorpenetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci. Transl. Med. 4, 147ra112 (2012).
49. Chevillard G, Blank V. NFE2L3 (NRF3): the Cinderella of the Cap'n'Collar transcription factors. Cell. Mol. Life Sci. 68, 3337-3348 (2011).
50. Rhee DK, Park SH, Jang YK. Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model. Genomics 92, 419-428 (2008).
51. Almstrup K, Leffers H, Lothe RA et al. Improved gene expression signature of testicular carcinoma in situ. Int. J. Androl. 30, 292-302 (2007).
52. Wang Y, van der Zee M, Fodde R, Blok LJ. Wnt/ Beta-catenin and sex hormone signaling in endometrial homeostasis and cancer. Oncotarget 1, 674-684 (2010).
53. Matsuzaki S, Darcha C. In vitro effects of a small-molecule antagonist of the Tcf/-catenin complex on endometrial and endometriotic cells of patients with endometriosis. PLoS ONE 8, e61690 (2013).
54. Kobayashi A, Behringer RR. Developmental genetics of the female reproductive tract in mammals. Nat. Rev. Genet. 4, 969-980 (2003).
55. Martini M, Ciccarone M, Garganese G et al. Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosis. Int. J. Cancer 102, 398-406 (2002).
56. Miao R, Guo X, Zhi Q et al. VEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer. PLoS ONE 8, e74409 (2013).
57. WERF Endometriosis Phenome and Biobanking Harmonisation Project (EPHect). www.endometriosisfoundation.org/ephect
58. Michailidou K, Hall P, Gonzalez-Neira A et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45(4), 353-361 (2013).
59. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am. J. Hum. Genet. 90, 7-24 (2012).
60. Story L, Kennedy S. Animal studies in endometriosis: a review. ILAR J. 45(2), 132-138 (2004).
61. Zondervan K, Cardon L, Desrosiers R et al. The genetic epidemiology of spontaneous endometriosis in the rhesus monkey. Ann. N. Y. Acad. Sci. 955, 233-238 (2002).